Inventor · disambiguated record
Thomas A. Armer
Also filed as: ARMER THOMAS · ARMER THOMAS A · ARMER THOMAS ALEX
51 granted patents·40 pending applications·1,357 citations·filing 1987–2024
99Inventor score
Files withMAP PHARMACEUTICALS INC29XOC PHARMACEUTICALS INC14OLIN CORP8AI THERAPEUTICS INC6COOK ROBERT O6
Top patents by PatentIndex Score
91 records- 0195US7994197B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2009·Granted Aug 9, 2011·28 cites·32 claims
- 0294US9365591B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·12 cites·1 claims
- 0394US8946420B2Neuromodulatory compoundsCOOK ROBERT O·Filed 2012·Granted Feb 3, 2015·15 cites·20 claims
- 0494US8604035B2Fluoroergoline analogsCOOK ROBERT O·Filed 2012·Granted Dec 10, 2013·25 cites·16 claims
- 0594US8119639B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileCOOK ROBERT O·Filed 2010·Granted Feb 21, 2012·28 cites·14 claims
- 0693US11103449B2Inhalable rapamycin formulation for treating age-related conditionsAI THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·4 cites·13 claims
- 0793US8933093B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2013·Granted Jan 13, 2015·15 cites·4 claims
- 0893US8927567B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2013·Granted Jan 6, 2015·15 cites·3 claims
- 0993US8841448B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2013·Granted Sep 23, 2014·15 cites·17 claims
- 1092US11491143B2Inhalable rapamycin formulation for the treatment of pulmonary hypertensionAI THERAPEUTICS INC·Filed 2019·Granted Nov 8, 2022·3 cites·14 claims
- 1192US9815830B2Isoergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Nov 14, 2017·6 cites·15 claims
- 1292US9777016B2Isoergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Oct 3, 2017·6 cites·12 claims
- 1392US9657020B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·10 cites·34 claims
- 1492US9150593B2Fluoroergoline analogsMAP PHARMACEUTICALS INC·Filed 2014·Granted Oct 6, 2015·12 cites·11 claims
- 1591US9676776B2Isoergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2016·Granted Jun 13, 2017·6 cites·37 claims
- 1691US9012640B2Cabergoline derivativesZHANG JIAN·Filed 2012·Granted Apr 21, 2015·15 cites·5 claims
- 1791US8710092B2Substituted indolo 4,3 FG quinolines useful for treating migraineZHANG JIAN·Filed 2010·Granted Apr 29, 2014·24 cites·19 claims
- 1891US5954047AMethods and apparatus for delivering aerosolized medicationSYSTEMIC PULMONARY DEV LTD·Filed 1997·Granted Sep 21, 1999·316 cites·21 claims
- 1990US9951070B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Apr 24, 2018·6 cites·16 claims
- 2090US9938277B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2017·Granted Apr 10, 2018·7 cites·18 claims
- 2189US11648199B2Inhalable rapamycin formulation for treating age-related conditionsAI THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·1 cites·14 claims
- 2289US9394314B28′-hydroxy-dihydroergotamine compounds and compositionsMAP PHARMACEUTICALS INC·Filed 2013·Granted Jul 19, 2016·13 cites·11 claims
- 2389US8148377B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileCOOK ROBERT O·Filed 2008·Granted Apr 3, 2012·9 cites·25 claims
- 2487US11123289B2Rapamycin for the treatment of lymphangioleiomyomatosisAL THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·2 cites·12 claims
- 2587US10307371B2Rapamycin for the treatment of lymphangioleiomyomatosisAI THERAPEUTICS INC·Filed 2017·Granted Jun 4, 2019·6 cites·7 claims
- 2687US9833451B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·4 cites·4 claims
- 2786US10307370B2Rapamycin for the treatment of lymphangioleiomyomatosisLAM THERAPEUTICS INC·Filed 2014·Granted Jun 4, 2019·6 cites·19 claims
- 2886US10308651B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·3 cites·13 claims
- 2986US10246458B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted Apr 2, 2019·3 cites·16 claims
- 3086US5144412AProcess for manufacturing plastic pin grid arrays and the product produced therebyOLIN CORP·Filed 1990·Granted Sep 1, 1992·101 cites·31 claims
- 3184US10703753B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·1 cites·12 claims
- 3283US2023240986A1Inhalable rapamycin formulation for treating age-related conditionsAI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3382US10301311B2Polycyclic compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·3 cites·16 claims
- 3482US4948641AMultiple layer container for storage of high purity chemicalsOLIN CORP·Filed 1989·Granted Aug 14, 1990·44 cites·6 claims
- 3581US12171874B2Rapamycin for the treatment of lymphangioleiomyomatosisORPHAI THERAPEUTICS INC·Filed 2023·Granted Dec 24, 2024·0 cites·13 claims
- 3681US6095141AMethods and apparatus for delivering aerosolized medicationSHEFFIELD PHARMACEUTICALS INC·Filed 1999·Granted Aug 1, 2000·167 cites·8 claims
- 3781US4965227AProcess for manufacturing plastic pin grid arrays and the product produced therebyOLIN CORP·Filed 1988·Granted Oct 23, 1990·60 cites·35 claims
- 3880US6026808AMethods and apparatus for delivering aerosolized medicationSHEFFIELD PHARMACEUTICALS INC·Filed 1999·Granted Feb 22, 2000·159 cites·10 claims
- 3980US4816426AProcess for manufacturing plastic pin grid arrays and the product produced therebyOLIN CORP·Filed 1987·Granted Mar 28, 1989·57 cites·25 claims
- 4080US2024285524A1Inhalable rapamycin formulation for treating age-related conditionsORPHAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4179US10464936B2Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·1 cites·15 claims
- 4278US10172853B2Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·1 cites·17 claims
- 4375US11744797B2Rapamycin for the treatment of lymphangioleiomyomatosisAL THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·0 cites·12 claims
- 4475US2023255944A1Inhalable rapamycin formulation for the treatment of pulmonary hypertensionAI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4571US2020352939A1Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4671US2021115042A1Ergoline compounds and uses thereofXOC PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4770US4871618ALaminar structures prepared with polyketone structural adhesivesSHELL OIL CO·Filed 1987·Granted Oct 3, 1989·25 cites·8 claims
- 4869US2009149432A1Methods for administering corticosteroid formulationsSHREWSBURY STEPHEN B·Filed 2008·Application pending·0 cites
- 4968US2019247393A1Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profileMAP PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 5067US6527151B1Aerosol air flow control system and methodSHEFFIELD PHARMACEUTICALS INC·Filed 2000·Granted Mar 4, 2003·41 cites·21 claims
Showing the top 50 of 91 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →